News and blog posts
22
Jan 2020
With a regional decree of December 18, 2019, Tuscany Regional Healthcare has published assessments of thirteen medical devices belonging to various therapeutic areas.
Read more
21
Jan 2020
The Clinical Coding and Schedule Development (CCSD) group develops and maintains procedural and diagnostics nomenclature for private payers in England. New procedure codes concern removal of pectus bar, open surgical correction of pectus deformity of the chest wall, intradermal injection into the scalp, nerve and neurolytic root block with or without image guidance, facet joint injection with or without image guidance and diagnostic code for gustatory testing. The codes are introduced with a recommended adoption date being the 1st of May 2020. The documents also contain a list of textual changes in codes, unacceptable combinations, and inactivated codes.
Read more
20
Jan 2020
On the week of the 13th of January, MTRC published several posts related to the upcoming change of the UK payment system, the top categories of medical devices evaluated by HTA organizations in Europe, the criteria for the creation of a new OPS procedure code in Germany, medical devices added to the High-Cost Device List in England in April 2020, the factors affecting the decision to introduce a new technology, and the least common topics of Med Tech HTA in Europe. Follow us on Instagram on @mtrc.market.access
Read more
20
Jan 2020
The French National Authority for Health (HAS) regularly publishes new decisions about add-on reimbursement for medical devices. The decisions made in December 2019 concern various types of devices, mostly for cardiovascular devices. A total of five decisions were made.
Read more
A new form of DNA testing “whole-exome sequencing” for critically ill babies and children on the NHS
17
Jan 2020
The NHS in England is providing a new form of DNA test capable of quickly diagnosing rare diseases for critically ill babies and children, as part of its Long Term Plan to use world-leading technologies to improve care for the sickest infants.
Read more
16
Jan 2020
In this post, we have summarized all the important developments with our services and products, which can be used by Med Tech, IVD and digital health companies to achieve better outcomes of the market access activities. This includes expansion of geographical coverage, growth in number of topics covered by the ready-made reimbursement reports, expertise in the e-health space, new services of health economics and value dossier, new free resources on market access, online educational materials on market access. Let us know, if you need any support with market access in European countries.
Read more
16
Jan 2020
New material codes for implantable non-rechargeable neurostimulator, electrodes, and extensions for stimulation of the dorsal root nodes were added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) in December 2019.
Read more
15
Jan 2020
Dutch Healthcare Authority (NZa) has released key features of the DRG package for 2021, including complex chronic lung failure, stem cell transplant care, indexation of DRG tariffs, and position about reimbursment of MammaPrint test.
Read more
14
Jan 2020
In December 2019, the National Institute for Health and Care Excellence (NICE) published one new interventional procedure guidance (for balloon dilation for chronic eustachian tube dysfunction), one new medical technologies guidance (for gammaCore for cluster headache), and five new MedTech innovation briefings (for Optowire for measuring fractional flow reserve, eXroid for internal hemorrhoids, and others).
Read more
13
Jan 2020
In mid-December 2019, the Swiss Federal Department for Home Affairs (FDHA) has decided that two new autologous cell therapies (CAR-T therapies) for the treatment of leukemia and lymphoma will be reimbursed by compulsory health care insurance.
Read more
11
Jan 2020
On the week of 6th of January, MTRC published several posts related to the process of DRG change in England, list of technologies with different levels of added value (ASA) in France, countries offering access to hospital procedure volume information, improvements with glaucoma minimally invasive surgery reimbursement in England, the role of DRG in Scandinavia, and list of countries actively using DRG system for case-by-case reimbursement. Follow us on Instagram on mtrc.market.access
Read more
07
Jan 2020
In mid-November 2019, the report of the project OTCA20, titled “Prophylactic or therapeutic use of endoanchoring systems in endovascular aortic aneurysm repair (EVAR/TEVAR)” was published on the website of the European Network for HTA (EUnetHTA).
Read more